Identification of pongamol and karanjin as lead compounds with antihyperglycemic activity from Pongamia pinnata fruits

Journal of Ethnopharmacology

Volumn 118, Issue 3, 2008, Pages 435-439

  Tamrakar, Akhilesh K ^a   Yadav, Prem P ^a   Tiwari, Priti ^a   Maurya, Rakesh ^a   Srivastava, Arvind K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antihyperglycemic activity; Fabaceae; Pongamia pinnata

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; KARANJIN; METFORMIN; PONGAMIA PINNATA EXTRACT; PONGAMOL; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG IDENTIFICATION; DRUG ISOLATION; ENZYME INHIBITION; FRUIT; GLUCOSE BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PONGAMIA; PONGAMIA PINNATA; RAT; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES;

3T3-L1 CELLS; ANIMALS; BENZOFURANS; BENZOPYRANS; DIABETES MELLITUS, EXPERIMENTAL; FRUIT; HYPOGLYCEMIC AGENTS; MALE; MICE; MILLETTIA; PHOSPHOPROTEIN PHOSPHATASES; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

FABACEAE; MUS; PONGAMIA PINNATA; RATTUS;

EID: 47749089690     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.05.008     Document Type: Article

References (23)

1. Ahmad F., Azevedo J.L., Cortright R., Dohm G.L., and Goldstein B.J. Alterations in skeletal muscle protein tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. Journal of Clinical Investigation 100 (1997) 449-458
2. Ahmad F., Considine R.V., and Goldstein B.J. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR account for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. Journal of Clinical Investigation 95 (1995) 2806-2812
3. Ahmad F., and Goldstein B.J. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus. Metabolism 44 (1995) 1175-1184
4. Ahmad F., and Goldstein B.J. Purification, identification and subcellular distribution of three predominant protein-tyrosine phosphatase enzymes in skeletal muscle tissue. Biochimica Biophysica Acta 1248 (1995) 57-69
5. Ahmad I., Adeghate E., Cummings E., Sharma A.K., and Singh J. Beneficial effects and mechanism of action of Marmordica charantia juice in the treatment of streptozotocin induced diabetes mellitus in rat. Molecular and Cellular Biochemistry 261 (2004) 63-70
6. Boylan J.M., Brautigan D.L., Madden J., Raveen T., Ellis L., and Gruppuso P.A. Differential regulation of multiple hepatic protein tyrosine phosphatases in alloxan diabetic rats. Journal of Clinical Investigation 90 (1992) 174-179
7. Cheng A., Dube N., Gu F., and Tremblay M.L. Coordinated action of protein tyrosine phosphatases in insulin signal transduction. European Journal of Biochemistry 269 (2002) 1050-1059
8. Cheung A., Kusari J., Jansen D., Bandyopadhyay D., Kusari A., and Bryer-Ash M. Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. Journal of Laboratory and Clinical Medicine 134 (1999) 115-123
9. Coleman D.L. Obese and Diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14 (1978) 141-148
10. Goldstein B.J., Bitter-Kowalezyk A., White M.F., and Harbeck M. Dephosphorylation and deactivation of insulin receptor substrate-1 by protein tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb 2 adaptor protein. Journal of Biological Chemistry 275 (2000) 4283-4289
11. Hauguel-de Mouzon S., Peraldi P., Alengrin F., and Van Obberghen E. Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats. Endocrinology 132 (1993) 67-74
12. Kirtikar K.R., and Basu B.D. Indian Medicinal Plants. second ed Vol. 1 (1995), International Book Distributors, Dehradun, India
13. Koyabashi K., Forte T.M., Taniguchi S., Ishida B.Y., Oka K., and Chan L. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effect of western diet feeding. Metabolism 49 (2000) 22-31
14. Krishnamurthi A. The Wealth of India, Publication and Information Directorate Vol. VIII (1969), CSIR, New Delhi, India
15. Mandal B., and Maity C.R. Hypoglycemic action of karanjin. Acta Physiologica et Pharmacologica Bulgarica 12 (1987) 42-46
16. Meyerovitch J., Backer J.M., and Kahn C.R. Hepatic phosphotyrosine phosphatase activity and its alteration in diabetic rats. Journal of Clinical Investigation 84 (1989) 976-983
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65 (1983) 55-63
18. Oh W.K., Lee C.H., Lee M.S., Bae E.Y., Sohn C.B., Oh H., Kim B.Y., and Ahn J.S. Antidiabetic effects of extracts from Psidium guajava. Journal of Ethnopharmacology 96 (2005) 411-415
19. Punitha R., and Manoharan S. Antihyperglycemic and antilipidperoxidative effects of Pongamia pinnata (Linn.) Pierre flowers in alloxan-induced diabetic rats. Journal of Ethnopharmacology 105 (2006) 39-46
20. Saltiel A.R. New perspectives into the molecular patho-genesis and treatment of type 2 diabetes. Cell 104 (2001) 517-529
21. Saltiel A.R., and Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
22. Szkudelski T. The mechanism of alloxan and streptozotocin action in β-cells of the rat pancreas. Physiological Research 50 (2001) 536-546
23. Yadav P.P., Ahmad G., and Maurya R. Furanoflavonoids from Pongamia pinnata fruits. Phytochemistry 65 (2004) 439-443